Cite
HARVARD Citation
Reizine, N. et al. (2021). Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid‐Treated Oncology Patients. Oncologist. pp. e2042-e2052. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reizine, N. et al. (2021). Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid‐Treated Oncology Patients. Oncologist. pp. e2042-e2052. [Online].